ZA200301672B - Compositions and dosage forms for application in the oral cavity in the treatment of mykoses. - Google Patents

Compositions and dosage forms for application in the oral cavity in the treatment of mykoses. Download PDF

Info

Publication number
ZA200301672B
ZA200301672B ZA200301672A ZA200301672A ZA200301672B ZA 200301672 B ZA200301672 B ZA 200301672B ZA 200301672 A ZA200301672 A ZA 200301672A ZA 200301672 A ZA200301672 A ZA 200301672A ZA 200301672 B ZA200301672 B ZA 200301672B
Authority
ZA
South Africa
Prior art keywords
dosage form
form according
active ingredient
treatment
application
Prior art date
Application number
ZA200301672A
Other languages
English (en)
Inventor
Gunther Berndl
Joerg Breitenbach
Joerg Neumann
Joerg Rosenberg
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of ZA200301672B publication Critical patent/ZA200301672B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
ZA200301672A 2000-08-03 2003-02-28 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses. ZA200301672B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10038571A DE10038571A1 (de) 2000-08-03 2000-08-03 Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen

Publications (1)

Publication Number Publication Date
ZA200301672B true ZA200301672B (en) 2004-03-01

Family

ID=7651652

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200301672A ZA200301672B (en) 2000-08-03 2003-02-28 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses.

Country Status (13)

Country Link
US (1) US20040029892A1 (de)
EP (1) EP1305010B1 (de)
JP (1) JP2004505905A (de)
CN (1) CN1274297C (de)
AT (1) ATE262893T1 (de)
AU (1) AU2001295448A1 (de)
BR (1) BR0112847A (de)
CA (1) CA2417709C (de)
DE (2) DE10038571A1 (de)
ES (1) ES2218456T3 (de)
RU (1) RU2003105812A (de)
WO (1) WO2002011694A2 (de)
ZA (1) ZA200301672B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175205B1 (de) * 1999-11-12 2006-06-14 Abbott Laboratories Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
EP1446167A4 (de) * 2001-11-05 2010-09-29 Orahealth Corp Behandlung von geschwüren mit pflastern zur beschleunigung der heilung und linderung von schmerzen
WO2004004683A1 (en) * 2002-07-04 2004-01-15 Janssen Pharmaceutica N.V. Solid dispersions comprising two different polymer matrixes
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
JP2007517016A (ja) 2003-12-31 2007-06-28 ファイザー・プロダクツ・インク 低溶解性薬剤及びポロキサマーの固体組成物
CN1294912C (zh) * 2004-03-01 2007-01-17 上海医药工业研究院 伊曲康唑盐酸盐组合物及其冻干粉针
JP2006096728A (ja) * 2004-09-30 2006-04-13 Kobayashi Pharmaceut Co Ltd 口腔内定着型固形製剤
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
AU2007268240B2 (en) * 2006-05-23 2012-12-06 Orahealth Corporation Xylitol troches and methods of use
CN101108172B (zh) * 2006-07-17 2010-10-06 天津药物研究院 一种口腔粘贴片及其制备方法
GB0703998D0 (en) 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
JP2014503470A (ja) * 2010-10-14 2014-02-13 アボット ゲーエムベーハー ウント カンパニー カーゲー クルクミノイド固体分散製剤
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (de) * 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
US5431915A (en) * 1993-12-20 1995-07-11 Harvey; Bryce M. Frozen oral medication delivery system and method
JPH0920680A (ja) * 1995-01-24 1997-01-21 Hideyo Yamaguchi 抗真菌剤
DE19539359A1 (de) * 1995-10-23 1997-04-24 Knoll Ag Formbandkalander
WO1997044014A1 (en) * 1996-05-20 1997-11-27 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen

Also Published As

Publication number Publication date
CA2417709C (en) 2010-05-11
US20040029892A1 (en) 2004-02-12
EP1305010A2 (de) 2003-05-02
WO2002011694A3 (en) 2002-04-25
BR0112847A (pt) 2003-06-24
DE60102590T2 (de) 2005-04-21
CN1444473A (zh) 2003-09-24
CA2417709A1 (en) 2002-02-14
DE10038571A1 (de) 2002-02-14
EP1305010B1 (de) 2004-03-31
ATE262893T1 (de) 2004-04-15
JP2004505905A (ja) 2004-02-26
DE60102590D1 (de) 2004-05-06
WO2002011694A2 (en) 2002-02-14
ES2218456T3 (es) 2004-11-16
AU2001295448A1 (en) 2002-02-18
CN1274297C (zh) 2006-09-13
RU2003105812A (ru) 2004-09-27

Similar Documents

Publication Publication Date Title
EP1305010B1 (de) Darreichungsformen zur behandlung von oralen mykosen
JP3391801B2 (ja) 向上した生物学的利用性を有する抗菌性組成物
US9744170B2 (en) Solid antiviral dosage forms
KR20090094815A (ko) 티로신 키나아제 억제제의 경구 투여를 위한 약제 투여형
CN101262852A (zh) 稳定活性药物成分的组合物和方法
HU207948B (en) Process for producing oral pimobendane compositions
US9149431B2 (en) Itraconazole compositions with improved bioavailability
HU221614B (hu) Nem-szteroid analgetikumok átlátszó, gyors hatóanyag-kibocsátású készítményei és eljárás előállításukra
JP2005518418A (ja) 浸透圧による送達システム
HUT73657A (en) Compositions in the form of solid solutions, containing coumarin derivatives
KR20080030677A (ko) 구강내 속붕괴성 정제
EP2802311B1 (de) Sublinguale pharmazeutische zusammensetzung mit einem antimuskarinischen wirkstoff und herstellungsverfahren dafür
US20100272800A1 (en) Orally disintegrating olanzapine tablet
CN108024964B (zh) 用于治疗hcv的固体药物组合物
US20250255967A9 (en) Novel use of polymer combination
US20240285771A1 (en) Rapidly disintegrating oral thin-films/foams having a high active-ingredient content based on a mixture of polyvinyl alcohols having various molecular weights
GB2625584A (en) Novel composition